Previous studies demonstrated a multiplicity of isomers of inositol phosphates in GH3 rat pituitary tumour cells. In order to determine their origin, we have investigated the metabolism of radiolabelled inositol phosphates (IP.) in GH3 cell homogenates by using h.p.l.c. 1(1,4,5)P3 is either phosphorylated to 1(1,3,4,5)P4
INTRODUCTION
The hydrolysis of PIP2 by phospholipase C yields two second messengers, I(1,4,5)P3 and DAG. I(1,4,5)P3 releases Ca2" from intracellular stores and DAG activates protein kinase C (Berridge & Irvine, 1984; Nishizuka, 1984) . The subsequent metabolism of I(1,4,5)P3 is of considerable interest because of the potential role of other inositol phosphates in regulating intracellular Ca2" (Irvine & Moor, 1986; Irvine et al., 1986b) . We have previously investigated the changes which occur in levels of individual radiolabelled inositol phosphate isomers in the GH3 rat pituitary tumour cell line in response to thyrotropin-releasing hormone (TRH) . These studies revealed a complex pattern of inositol phosphates, some of which remained unidentified, with different kinetic patterns.
Consequently we have addressed a number of specific points raised by these studies: the source of I(4)P, the identity of the unknown IP2 isomers, and the pathways by which (1l,3,4,5)P4 is both generated and metabolized. We have also investigated GH3 cells for the presence of more highly phosphorylated inositol phosphates (IP5 and 1P6).
EXPERIMENTAL Materials and h.p.l.c.
Radiolabelled phosphoinositol lipids and inositol phosphates were obtained from Amersham International, Des Plaines, IL, U.S.A., and du Pont/NEN Products, Boston, MA, U.S.A. 3H-labelled inositol phosphates for use as h.p.l.c. standards were prepared as described previously . H.p.l.c. separations were performed on a Whatman Partisil 10 SAX column (25 cm x 0.46 cm) with a pre-column containing Whatman pellicular anion-exchange resin. Elution was by ammonium phosphate (pH 3.8) gradients at a flow rate of 1 ml/min, and 0.5 ml fractions were collected. The gradients used are described in their respective experiments. Fractions were mixed with 6 ml of Aqueous Counting Scintillant (Amersham International) containing 5 % (v/v) water, and radioactivity was determined by liquid-scintillation counting. GH3 cells GH3 cells were grown as described previously .
Hydrolysis of inositol phosphates GH3 cells were removed from two 150 cm3 flasks by use of a cell scraper and suspended in 0.9 % NaCl with 0.02% EDTA, then collected by centrifugation (1000 g, 2 min). The cells were suspended in 0.7 ml of 0.2 M-Tris/ HCI, pH 7.6, with 2 mM-EDTA and allowed to swell on ice for 10 min. Homogenates were then prepared by 10-20 strokes ofa glass/Teflon homogenizer. The protein concentration in these homogenates was 6-10 mg/ml as determined by the method of Smith et al. (1985) . Incubations were performed at 37°C in a total volume of Vol. 250 Abbreviations used: DAG, diacylglycerol; GPI, glycerophosphoinositol; GPIP, glycerophosphoinositol phosphate (similarly GPIP2, GPIP3, GPIP4 and GPIP5); IP, myo-inositol monophosphate; 1P2, myo-inositol bisphosphate (similarly 1P3, 1P4, IP5 and IP6, with locants designating specific isomers where appropriate and assumed to be D-enantiomers unless otherwise stated); PI, phosphatidylinositol; PIP, phosphatidylinositol phosphate (similarly PIP2 and PIP3); TRH, thyrotropin-releasing hormone.
* To whom correspondence and reprint requests should be sent.
0.375 ml consisting of 0.3 ml of buffer (10 mM-Hepes/ 4 mM-MgCl2/10 mM-KCI/1 mM-EGTA, pH.7.2),0.05 ml of cell homogenate and 25,l of radiolabelled substrate at 1,uCi/ 100 1l. Portions of the reaction mixture (75,tl) were removed at the indicated times and mixed with S u1 of 150% trichloroacetic acid to terminate the reaction.
The trichloroacetic acid was removed by three extractions with water-saturated diethyl ether. Samples were stored at -20°C until analysed. This technique was used to examine the hydrolysis with time of I(1,4)P2, I(1,4,5)P3, I(1,3,4,5)P4 (all at 0.7 nM) and IP5 (extracted from GH3 cells).
In order to determine whether GH3 cells contain an IP3 kinase, cell homogenates were prepared as described, and 50,ul added to 250 nCi of [3H]I(1,4,5)P3 in 325,ul buffer (10 mM-NaCl/70 mM-potassium glutamate/ 30 mM-KCl/4 mM-MgCl2/10 mM-Hepes/1 mM-EGTA/ 5 or 10 mM-ATP, pH 7.4). Portions of the reaction mixture (75 ,tl) were removed at different times (up to 30 min) and the reaction terminated with 5 jl of 15 00 (w/v) trichloroacetic acid. The supernatant was extracted three times with water-saturated diethyl ether, and the products formed were examined by h.p.l.c.
We have also examined the hydrolysis of [3H]I(1,4)P2 by rat liver homogenates. Rat liver was homogenized in 0.5 M-sucrose, and incubations with [3H]I(1,4)P2 were performed with portions of the homogenate (25 mg of liver/ml of 0.5 M-sucrose) exactly as described by Storey et al. (1984) . radioactivity 1 Ci/mmol) (Amersham International) and a 400 nCi portion of [4,5-32P]I(1,4,5)P3 (sp. radioactivity 20-200 Ci/mmol) (du Pont/NEN) were combined and dried under N2. These were reconstituted in 1 ml of 100 mM-Tricine, pH 8, containing 10 mM-MgCl2, 3 mm-2,3-diphosphoglycerate and 10 mM-ATP (disodium salt) (Sigma). To this was added 50 #u1 of a 40 (w/v) rat brain homogenate (in 0.15 M-sucrose), the mixture was vortexmixed and incubated for 15 min at 37 'C. The reaction was terminated by the addition of 0.5 ml of 300 trichloroacetic acid (4°C to confirm this designation, the remaining pooled [3H]-inositol-labelled extract was separated as described above and the putative IP5 and IP6 recovered from the column. In order to desalt the compounds, each was diluted to 40 ml with distilled water and applied to 5 ml of Dowex-1 (Cl-) anion-exchange resin (Sigma) and eluted by a modification of the method of Cosgrove (1969) . First, the columns were washed with distilled water (10 ml) and then 0.05 M-HCI (20 ml) to remove Pi.
IP5 was eluted with 20 ml of 0.6 M-HCI and IP6 with 20 ml of 0.75 M-HCI. The desalted samples were freezedried and reconstituted in 0.5 ml of distilled water.
Confirmation of the identity of IP5 and IP6 was obtained by co-migration with unlabelled IP5 or IP6 (Calbiochem-Behring Corp., La Jolla, CA, U.S.A.) on electrophoresis plates (20 cm x 20 cm t.l.c. cellulose plates; Eastman-Kodak; 400 V/ 150 mA in 0.1 M-oxalic acid). The unlabelled standards were located with a phosphate-detecting acid-molybdate spray reagent (Sigma), and the labelled compounds from GH3 cells were located by scraping the plates into strips and counting the radioactivity. (Hawkins et al., 1986) , and the extract was separated by h.p.l.c. with the gradient described in Fig.  1 ; however, no peaks corresponding to GPIP3, GPIP4 or GPIP5 were found, indicating that GH3 cells do not contain PIP3, PIP4 or PIP5. A similar preparation of deacylated [3H]inositol-labelled lipid was treated with 1 mM-sodium periodate to produce inositol phosphate isomers with the same phosphate configuration as the parent lipids (Brown & Stewart, 1966; Heslop et al., 1986) . After separation by h.p.l.c., peaks of radioactivity corresponding to I(1)P, I(1,4)P2 and I(1,4,5)P3 were found, with no peaks corresponding to I(4)P or I(1,3,4)P3, confirming the conventional isomeric configuration for inositol lipids in these cells.
RESULTS AND DISCUSSION I(1,4)P2 metabolism Incubation of I(1,4)P2 with GH3 cell homogenates results in the formation of I(4)P, with no appreciable accumulation of I(1)P and a much slower accumulation of inositol (Fig. 2) ; thus the dephosphorylation of 1(1,4)P2 is highly specific and proceeds via the action of an I(1,4)P2 1-phosphatase. and so have assumed that I(1)P is exclusively formed from 1(1,4)P2. In a second study, Storey et al. (1984) have described the hydrolysis of I(1,4)P2 by rat liver homogenates. These workers also used I[4-32P](1,4)P2 as a substrate and concluded that the 1-and 4-phosphate groups of 1(1,4)P2 are removed at approximately the same rate, presumably yielding equal amounts of I(1)P and I(4)P. Because of our results in GH3 cells, we have re-examined the hydrolysis of 1(1,4)P2 by rat liver homogenates using [3H]I(1,4)2 under conditions identical with those used by Storey et al. (1984) and have separated the 3H-labelled metabolic products by h.p.l.c. I(4)P was found to be formed almost exclusively (-98 %), with only a trace of I(1)P. The 1(1,4)P2 l-phosphatase activity from rat liver has been partially purified and characterized . It seems likely that the direct separation of I(1)P from I(4)P by h.p.l.c. is a more accurate method of determining the products of hydrolysis of I(1,4)P2 than resolving [32P]P1 from I[4-32P](4)P, which was required in the previous studies.
In GH3 cells treated with TRH and LiCl, I(4)P is the predominant monophosphate formed, and increases rapidly ( -10 s) after stimulation, whereas I(1)P does not increase until 60-90 s after TRH treatment . As we have demonstrated that I(4)P is the major (or exclusive) product of 1(1,4)P2 hydrolysis, these kinetic studies reported previously indicate that no change in PI hydrolysis is occurring in these cells over the first 60-90 s of stimulation. The subsequent increase in I(I)P could result from either 1(1,3,4)P3 metabolism or increased PI hydrolysis by phospholipase C. The sustained increase in I(4)P in GH3 cells for up to 30 min 1,4,5) P3 with saponin-permeabilized rat anteriorpituitary cells and demonstrated the exclusive accumulation of I(4)P rather than I(1)P. Similarly, Ackermann et al. (1987) hydrolysed 1(1,4)P2 with a dialysed rat brain preparation and showed that both I(4)P and I(1)P are formed, with I(4)P predominating. Subsequent to the completion of the present study, Inhorn et al. (1987) have described similar results to our own using calf brain as an enzyme source. They have partially purified an enzyme which specifically hydrolyses the 1-phosphate from both 1(1,4)P2 and 1(1,3,4)P3, and they conclude that the action of this enzyme on 1(1,4)P2 specifically and exclusively yields I(4)P, in agreement with our own observations in GH3 cells and liver extract. I(1,4,5)P3 metabolism Incubation of 1(1,4,5)P3 with GH3 cell homogenates in the absence of ATP results in the rapid, time-dependent, accumulation of 1(1,4)P2, which represents > 990 of the IP2 formed. When 5 or 10 mM-ATP is included in the incubation medium, there is an inhibition of 1(1,4,5)P3 hydrolysis (> 90 %) and an accumulation of 1(1,3,4,5)P4
(results not shown). These results are consistent with the hydrolysis of 1(1,4,5)P3 in GH3 cells by a highly specific, well-characterized, 5-phosphatase (Downes et al., 1982; Seyfred et al., 1984; Storey et al., 1984) or phosphorylation by the recently characterized I(1,4,5)P3 3-kinase (Irvine et al., 1986a) to produce I(1,3,4,5)P4 in an ATP-dependent reaction.
Although 1(1,4)P2 represents > 99 % of the IP2 hydrolysis products formed from I(1,4,5)P3, trace (<1 %) amounts of I(4,5)P2 are also generated, which may account for the very low levels of this isomer found in GH3 cells . I(1,3,4,5)P4 metabolism Hydrolysis of I(1,3,4,5)P4 by GH3 cell homogenates yields a complex pattern of products (Fig. 3) . The major ( 98 %) IP3 produced has a retention time identical with that of 1(1,3,4)P3. Prolonged incubation results in the hydrolysis of this compound to generate two novel IP2 isomers [the minor one ( 15 %) being eluted ahead of 1(1,4)P2, the major one (~85 %) being eluted after 1(1,4)P2] and two IP isomers, identified by their retention times as I(1)P and I(4)P. The accumulation of these isomers with time is shown in Fig. 4 .
The commercial preparation of [3H]I(1,3,4,5)P4 used in the present study contains a contaminating component (~10 % total radioactivity) which is eluted in the void volume (presumably [3H]inositol) and does not change appreciably during the time of incubation. There is also a minor (< 1 % total radioactivity) contaminant that is eluted in the position of I(1,4,5)P3 and approximately doubles in amount during the course of the incubation.
To enable full characterization of the isomers of inositol phosphate produced (particularly the unknown IP2 isomers), we have synthesized two different preparations of I (1, of inositol phosphates shown in Fig. 5(a) by dephosphorylation of I(1,3,4)P3 are I(I,3)P2, I(1,4)P2 and I(3,4)P2. Chromatography revealed that no 1(1,4)P2 is generated, and so our two unknown 1P2 isomers must be I(1,3)P2 and I(3,4)P2. Fig. 5(a) demonstrates that the largest of the two components [eluted after 1(1,4)P2] is 32P-labelled in the 4-position and consequently is identified as I(3,4)P2. By deduction the lesser 1P2 component generated, which is eluted ahead of 1(1,4)P2, must be I(1,3)P2. Hydrolysis of [3H,3-32P]I(l,3,4,5)P4 for 10 min yielded the profile of inositol phosphates shown in Fig. 5(b) , and the ratios of 32P/3H labelling are shown in Table 1 . As expected, 1(1,3,4)P3 has a similar 32P/3H ratio to 'P4. The second IP3 peak generated is 3H-labelled and not 32p-labelled, confirming its identify as 1(1,4,5)P3 [and not I(3,4,5)P3 or I(1,3,5)P3]. Both I(3,4)P2 and I(1,3)P2 are dual-labelled, again with ratios similar to that of 1(1,3,4,5)P4, confirming the presence of 32p label in the 3-phosphate position of both isomers. Unexpectedly the peak of radioactivity corresponding to I(l)P contains 32p labelling also, in a ratio (32P/3H) only slightly less than that of the precursor, 1(1,3,4,5)P4. This means that the I(1)P formed must be predominately L-I(l)P [or D-I(3)P] generated by the removal of the 4-phosphate from I(3,4)P2 or the 1-phosphate from I(1,3)P2. As anion-exchange chromatography achieves separation of different compounds by virtue of their different charge, enantiomers (D/L forms) will not be resolved. The 3H radioactivity in the [32P]P1 peak represents spill-over between channels, and only approx. 1 0 the total 32p radioactivity will appear as 3H (here a 32P/3H ratio of 75), which cannot account for a significant proportion of the 3H radioactivity seen in any inositol phosphate peaks.
The hydrolysis of I(1,3,4,5)P4 by a 5-phosphomonoesterase yielding I(1,3,4)P3 has been well documented with semi-purified enzyme (Connolly et al., 1987) , redcell membranes (Batty et al., 1985) , rat liver homogenate (Hansen et al., 1986) , rat parotid-gland homogenates (Hawkins et al., 1986) and permeabilized hepatocytes (Tennes et al., 1987) . Our results with GH3-cell homogenates are in agreement with these observations and suggest a source for the I(1,3,4)P3 found in GH3 cells . This is consistent with the proposal that 1(1,3,4,5)P4 metabolism in these cells proceeds primarily via the action of the 5-phosphomonoesterase to generate I(1,3,4)P3. A small amount of 1(1,4,5)P3 formation is consistently observed when 1(1,3,4,5)P4is incubated with cell homogenates; however, this represents a very minor (~2 % of IP3 radioactivity) route of metabolism relative to I(1,3,4)P3 formation. This is not, however, necessarily a general rule, as substantial amounts of I(1,4,5)P3 are generated from I (1, 3, 4, 5) , 3H radioactivity; ____, 32P radioactivity. The 32P/3H ratios of individual isomers are shown in Table 1 . Each experiment was repeated at least three times, with identical findings, and the values represent results from a single typical incubation.
GH3 cells and 2H3 cells (CunhaMelo et al., 1987) as well as I(1,4)P2. Previous studies by other workers have demonstrated two IP2 isomers in extracts of cells labelled with [3H]inositol (Heslop et al., 1985 (Heslop et al., , 1986 Hansen et al., 1986) . The earlier-to-be-eluted isomer has been identified as I(1,4)P2. Hansen et al. (1986) have suggested that the later-to-be-eluted compound is I(l,3)P2, whereas Heslop et al. (1986) Table 1 ). L-I(1)P is known to be formed in tissue by the isomerization of glucose 6-phosphate (Eisenberg & Maeda, 1985) . Ackermann et al. (1987) considered the possibility that in rat brain levels of I(1)P were increased owing to dephosphorylation of 1(1,3,4)P3, yielding L-I(1)P, but were able only to find 7-13 % of I(1)P present in the L form. This gives no indication, however, as to what percentage of L-I(1)P originates from -glucose 6-phosphate and what originates from 1(1,3,4)P3. If similar ratios of D/L forms of I(1)P exist in other tissues, it -would seem unlikely that I(1,3,4,5)P4 contributes significantly to the overall pool of I (1) (Chakrabarti & Biswas, 1981) . Hawkins et al. (1986) Our study provides information on the metabolic fate of different inositol phosphates in GH3 cells and suggests routes (Scheme 1) for the metabolism of individual isomers. The important points of this Scheme are that 1(1,4)P2 is exclusively dephosphorylated to I(4)P and that I(1)P accumulates by phospholipase C action on PI or the sequential dephosphorylation of 1(1,3,4)P3.
A similar general scheme has been proposed by Inhorn et al. (1987) on the basis of results obtained from enzymes purified from rat brain. Their scheme denotes a major hydrolysis of PI relative to PIP and PIP2. It seems likely, however, that the relative amounts of each lipid hydrolysed will differ from tissue to tissue. For example, Morgan et al. (1987) have demonstrated that, in pituitary gonadotrophs exposed to gonadotropin-releasing hormone, the inositol monophosphate accumulation is almost entirely I(4)P. Our own observations in GH3 cells are that both I(1)P and I(4)P accumulate, with the latter predominating . By contrast, in the rat basophilic leukaemia (RBL-2H3) cell stimulated with IgE, I(1)P accumulation is greater than I(4)P accumulation (Cunha-Melo et al., 1987) . This probably reflects different rates of hydrolysis of PI relative to PIP and PIP2. Whether these differences can be correlated with the different functions of individual cell types or the degree of differentiation remains to be seen. It is interesting to note that both cell types where I(4)P predominates are secretory cells (gonadotrophs and mammotrophs).
The present study has answered questions posed by our previous work . The IP2 isomer found in GH3 cells that is eluted ahead of 1(1,4)P2 is probably 1(1,3)P2, and the major isomer that is eluted after I(1,4)P2 is I(3,4)P2. We have also shown that 1(1 ,4)P2 is the source of I(4)P. Whether the metabolic pathways shown in Scheme 1 apply generally to all cell types remains to be determined.
